Dietary Tyrosine/Phenylalanine Depletion Effects on Behavioral and Brain Signatures of Human Motivational Processing
Dopamine (DA) neurotransmission is critical for motivational processing. We assessed whether disruption of DA synthesis in healthy controls using an amino-acid beverage devoid of catecholamine precursors (tyrosine-phenylalanine depletion (TPD)) would blunt recruitment of the nucleus accumbens (NAcc)...
Saved in:
Published in | Neuropsychopharmacology (New York, N.Y.) Vol. 39; no. 3; pp. 595 - 604 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Basingstoke
Nature Publishing Group
01.02.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Dopamine (DA) neurotransmission is critical for motivational processing. We assessed whether disruption of DA synthesis in healthy controls using an amino-acid beverage devoid of catecholamine precursors (tyrosine-phenylalanine depletion (TPD)) would blunt recruitment of the nucleus accumbens (NAcc) by rewards. Sixteen controls ingested each of a tyr/phe-depleting beverage (DEP) or a tyr/phe-balanced (BAL) control beverage in two laboratory visits. Five hours after consumption of each drink, subjects underwent functional magnetic resonance imaging while they viewed anticipatory cues to respond to a target to either win money or avoid losing money. TPD did not exert main effects on mood or on task behavior, but affected brain activation. In right NAcc, TPD blunted activation by anticipation of high rewards. In left NAcc, recruitment anticipating high rewards was modulated by individual differences in mood change across the DEP drink day, where subjects whose mood worsened following TPD (relative to within-day mood change under BAL conditions) also showed lower activation under DEP conditions relative to BAL conditions. Exploratory analysis indicated that TPD qualitatively blunted the voxel-wise spatial extent of suprathreshold activation by reward anticipation. Finally, loss outcomes activated anterior insula under DEP conditions but not under BAL conditions. These data indicate that: (1) dietary depletion of catacholamine precursors will blunt dopaminergic mesolimbic activity, and (2) in controls, synthetic pathways of this neurocircuitry maintain sufficient buffering capacity to resist an effect on motivated behavior. Additional studies are needed to determine if clinical populations would show similar resistance to behavioral effects of TPD. |
---|---|
AbstractList | Dopamine (DA) neurotransmission is critical for motivational processing. We assessed whether disruption of DA synthesis in healthy controls using an amino-acid beverage devoid of catecholamine precursors (tyrosine-phenylalanine depletion (TPD)) would blunt recruitment of the nucleus accumbens (NAcc) by rewards. Sixteen controls ingested each of a tyr/phe-depleting beverage (DEP) or a tyr/phe-balanced (BAL) control beverage in two laboratory visits. Five hours after consumption of each drink, subjects underwent functional magnetic resonance imaging while they viewed anticipatory cues to respond to a target to either win money or avoid losing money. TPD did not exert main effects on mood or on task behavior, but affected brain activation. In right NAcc, TPD blunted activation by anticipation of high rewards. In left NAcc, recruitment anticipating high rewards was modulated by individual differences in mood change across the DEP drink day, where subjects whose mood worsened following TPD (relative to within-day mood change under BAL conditions) also showed lower activation under DEP conditions relative to BAL conditions. Exploratory analysis indicated that TPD qualitatively blunted the voxel-wise spatial extent of suprathreshold activation by reward anticipation. Finally, loss outcomes activated anterior insula under DEP conditions but not under BAL conditions. These data indicate that: (1) dietary depletion of catacholamine precursors will blunt dopaminergic mesolimbic activity, and (2) in controls, synthetic pathways of this neurocircuitry maintain sufficient buffering capacity to resist an effect on motivated behavior. Additional studies are needed to determine if clinical populations would show similar resistance to behavioral effects of TPD. Dopamine (DA) neurotransmission is critical for motivational processing. We assessed whether disruption of DA synthesis in healthy controls using an amino-acid beverage devoid of catecholamine precursors (tyrosine-phenylalanine depletion (TPD)) would blunt recruitment of the nucleus accumbens (NAcc) by rewards. Sixteen controls ingested each of a tyr/phe-depleting beverage (DEP) or a tyr/phe-balanced (BAL) control beverage in two laboratory visits. Five hours after consumption of each drink, subjects underwent functional magnetic resonance imaging while they viewed anticipatory cues to respond to a target to either win money or avoid losing money. TPD did not exert main effects on mood or on task behavior, but affected brain activation. In right NAcc, TPD blunted activation by anticipation of high rewards. In left NAcc, recruitment anticipating high rewards was modulated by individual differences in mood change across the DEP drink day, where subjects whose mood worsened following TPD (relative to within-day mood change under BAL conditions) also showed lower activation under DEP conditions relative to BAL conditions. Exploratory analysis indicated that TPD qualitatively blunted the voxel-wise spatial extent of suprathreshold activation by reward anticipation. Finally, loss outcomes activated anterior insula under DEP conditions but not under BAL conditions. These data indicate that: (1) dietary depletion of catacholamine precursors will blunt dopaminergic mesolimbic activity, and (2) in controls, synthetic pathways of this neurocircuitry maintain sufficient buffering capacity to resist an effect on motivated behavior. Additional studies are needed to determine if clinical populations would show similar resistance to behavioral effects of TPD.Dopamine (DA) neurotransmission is critical for motivational processing. We assessed whether disruption of DA synthesis in healthy controls using an amino-acid beverage devoid of catecholamine precursors (tyrosine-phenylalanine depletion (TPD)) would blunt recruitment of the nucleus accumbens (NAcc) by rewards. Sixteen controls ingested each of a tyr/phe-depleting beverage (DEP) or a tyr/phe-balanced (BAL) control beverage in two laboratory visits. Five hours after consumption of each drink, subjects underwent functional magnetic resonance imaging while they viewed anticipatory cues to respond to a target to either win money or avoid losing money. TPD did not exert main effects on mood or on task behavior, but affected brain activation. In right NAcc, TPD blunted activation by anticipation of high rewards. In left NAcc, recruitment anticipating high rewards was modulated by individual differences in mood change across the DEP drink day, where subjects whose mood worsened following TPD (relative to within-day mood change under BAL conditions) also showed lower activation under DEP conditions relative to BAL conditions. Exploratory analysis indicated that TPD qualitatively blunted the voxel-wise spatial extent of suprathreshold activation by reward anticipation. Finally, loss outcomes activated anterior insula under DEP conditions but not under BAL conditions. These data indicate that: (1) dietary depletion of catacholamine precursors will blunt dopaminergic mesolimbic activity, and (2) in controls, synthetic pathways of this neurocircuitry maintain sufficient buffering capacity to resist an effect on motivated behavior. Additional studies are needed to determine if clinical populations would show similar resistance to behavioral effects of TPD. |
Author | Hommer, Daniel W Grant, Steven J Chen, Gang Bjork, James M |
Author_xml | – sequence: 1 givenname: James M surname: Bjork fullname: Bjork, James M – sequence: 2 givenname: Steven J surname: Grant fullname: Grant, Steven J – sequence: 3 givenname: Gang surname: Chen fullname: Chen, Gang – sequence: 4 givenname: Daniel W surname: Hommer fullname: Hommer, Daniel W |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28283131$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23995581$$D View this record in MEDLINE/PubMed |
BookMark | eNqNks1vFCEYh4mpsdvqzbOZxJh46GxhgAEuJvZDa1JjE_fQG2EZ2KWZhRGYTfa_l2m3fjQevABveN7f-3kEDnzwBoDXCM4RxPzUD8O8gQjPG9w8AzPECKxbTG4PwAxygWuE8e0hOErpDkJEWctfgMMGC0EpRzOQL5zJKu6qxS6G5Lw5vVkbv-tVr3yxqgsz9Ca74KtLa43OqSrPM7NWWxei6ivlu-osKuer727lVR6jKYitrsaN8tXXkN1WTe4FvYlBm1RirF6C51b1ybza38dg8elycX5VX3_7_OX843WtKUG5JnpJYdu2HabEwqXVGpJG6wbZZUu7luquHMgiLajAglBh-FJYiLgSuGMQH4MPD7LDuNyYThufS8pyiG5TKpZBOfn3j3druQpbibmgDWZF4P1eIIYfo0lZblzSpi-9MWFMEhHRcs6JaP4HhYwyKlBB3z5B78IYS4cmijGCGWGiUG_-TP5X1o-jK8C7PaCSVr2NymuXfnO84RjhiWseOF0GnKKxUrt8P5NSs-slgnLaI1n2SE57VCJM5Zw8cXrU_Sf-Ezdoyt0 |
CODEN | NEROEW |
CitedBy_id | crossref_primary_10_1016_j_tips_2014_04_002 crossref_primary_10_1038_npp_2015_313 crossref_primary_10_1016_j_euroneuro_2022_01_003 crossref_primary_10_1016_j_neubiorev_2017_06_003 crossref_primary_10_1016_j_neubiorev_2020_11_004 crossref_primary_10_1002_hbm_25400 crossref_primary_10_1038_s41386_021_00993_9 crossref_primary_10_1016_j_neuint_2017_03_003 crossref_primary_10_1038_npp_2016_143 crossref_primary_10_1177_0269881118758303 crossref_primary_10_3389_fnins_2018_00498 crossref_primary_10_1111_acer_15511 crossref_primary_10_3389_fnins_2018_00499 crossref_primary_10_1007_s00213_020_05693_8 crossref_primary_10_1177_1178646920964825 crossref_primary_10_1002_hbm_26645 crossref_primary_10_1093_ijnp_pyu084 crossref_primary_10_1038_s41583_018_0029_9 crossref_primary_10_1007_s00726_015_1919_z |
Cites_doi | 10.1111/j.1530-0277.2000.tb02012.x 10.1080/02791072.2000.10736099 10.1177/0269881110367731 10.1038/npp.2009.129 10.1016/j.tins.2007.03.007 10.1111/j.1476-5381.2009.00203.x 10.1016/0024-3205(96)00242-1 10.1016/j.jad.2011.09.048 10.1016/j.biopsych.2009.02.029 10.1177/026988119901300408 10.1038/sj.npp.1300665 10.1007/s002130050823 10.1016/S0006-2952(96)00774-5 10.1016/0006-2952(86)90071-7 10.1177/0269881111416686 10.1152/ajplegacy.1973.224.4.967 10.1017/S1092852900016837 10.1016/S0014-2999(01)01105-0 10.1152/physrev.1970.50.3.428 10.1017/S0033291700050856 10.1177/0269881105048886 10.1007/s002130050532 10.1523/JNEUROSCI.21-16-j0002.2001 10.1007/s00213-004-1945-0 10.1152/jn.00592.2011 10.1038/nrn1302 10.1523/JNEUROSCI.4862-03.2004 10.1037/0735-7044.121.5.887 10.1523/JNEUROSCI.2058-08.2008 10.1111/j.1471-4159.1976.tb07014.x 10.1126/science.1160873 10.1177/026988119901300205 10.1038/nn.2510 10.1002/ana.21594 10.1016/B978-0-12-374176-9.00025-7 10.1007/s002130000613 10.1016/j.neuroimage.2008.06.035 |
ContentType | Journal Article |
Copyright | 2015 INIST-CNRS Copyright Nature Publishing Group Feb 2014 Copyright © 2014 American College of Neuropsychopharmacology 2014 American College of Neuropsychopharmacology |
Copyright_xml | – notice: 2015 INIST-CNRS – notice: Copyright Nature Publishing Group Feb 2014 – notice: Copyright © 2014 American College of Neuropsychopharmacology 2014 American College of Neuropsychopharmacology |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 88G 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
DOI | 10.1038/npp.2013.232 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Psychology Database Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Neurosciences Abstracts ProQuest One Psychology MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | Tyrosine depletion and brain reward processing |
EISSN | 1740-634X |
EndPage | 604 |
ExternalDocumentID | PMC3895237 3181583971 23995581 28283131 10_1038_npp_2013_232 |
Genre | Randomized Controlled Trial Journal Article |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GrantInformation_xml | – fundername: Intramural NIH HHS grantid: ZIA AA000081 |
GroupedDBID | --- -DZ -Q- 0R~ 29N 2WC 36B 39C 4.4 406 5RE 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AANZL AASML AAYXX AAYZH ABAKF ABBRH ABDBE ABFSG ABIVO ABJNI ABLJU ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACMFV ACMJI ACPRK ACRQY ACSTC ACZOJ ADBBV ADFRT AEFQL AEJRE AEMSY AENEX AESKC AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AIXLP AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AOIJS ASPBG ATHPR AVWKF AYFIA AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BPHCQ BVXVI CCPQU CITATION CS3 DIK DNIVK DPUIP DWQXO E3Z EBLON EBS EE. EIOEI EJD EMB EMOBN F5P FDB FDQFY FERAY FIZPM FSGXE FYUFA GNUQQ GX1 HCIFZ HMCUK HYE HZ~ IWAJR JSO JZLTJ KQ8 M1P M2M M7P MK0 NQJWS O9- OK1 P2P P6G PHGZM PHGZT PQQKQ PROAC PSQYO PSYQQ Q2X RNT RNTTT ROL RPM SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TR2 UKHRP W2D ZGI --K 1B1 53G 5VS AACDK AAEDT AALRI AAQFI AAQXK AATNV AAXUO ABMAC ABWVN ACIUM ACRPL ADMUD ADNMO AILAN CAG COF FEDTE FGOYB FIGPU HVGLF IHE IQODW LGEZI LOTEE M41 NADUK NQ- NXXTH R2- RIG RNS RPZ SEW SSZ ZKB ABRTQ ACVFH ADCNI AEUPX AFPUW AGQPQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 3V. 7TK 7XB 8FE 8FH 8FK K9. LK8 PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c541t-4cb50666d354f0bfcc042cc21fb65d65cdd651f1c95939459e8b9f018a93d703 |
IEDL.DBID | 7X7 |
ISSN | 0893-133X 1740-634X |
IngestDate | Thu Aug 21 17:24:15 EDT 2025 Fri Jul 11 06:02:23 EDT 2025 Fri Jul 11 11:03:14 EDT 2025 Sat Aug 23 14:25:32 EDT 2025 Mon Jul 21 05:54:36 EDT 2025 Wed Apr 02 07:18:34 EDT 2025 Tue Jul 01 01:05:26 EDT 2025 Thu Apr 24 22:50:20 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Human Tyrosine Dopamine Phenylalanine Central nervous system Basal ganglion Corpus striatum Catecholamine Nuclear magnetic resonance imaging Feeding Encephalon fMRI Depletion Motivation Diet striatum Aminoacid Neurotransmitter Functional magnetic resonance imaging Behavior Reward |
Language | English |
License | http://www.springer.com/tdm CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c541t-4cb50666d354f0bfcc042cc21fb65d65cdd651f1c95939459e8b9f018a93d703 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 ObjectType-Article-2 ObjectType-Feature-1 Deceased. |
OpenAccessLink | https://www.nature.com/articles/npp2013232.pdf |
PMID | 23995581 |
PQID | 1477437479 |
PQPubID | 33935 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3895237 proquest_miscellaneous_1496888492 proquest_miscellaneous_1490757591 proquest_journals_1477437479 pubmed_primary_23995581 pascalfrancis_primary_28283131 crossref_citationtrail_10_1038_npp_2013_232 crossref_primary_10_1038_npp_2013_232 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-02-01 |
PublicationDateYYYYMMDD | 2014-02-01 |
PublicationDate_xml | – month: 02 year: 2014 text: 2014-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Basingstoke |
PublicationPlace_xml | – name: Basingstoke – name: England – name: New York |
PublicationTitle | Neuropsychopharmacology (New York, N.Y.) |
PublicationTitleAlternate | Neuropsychopharmacology |
PublicationYear | 2014 |
Publisher | Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group |
References | T Ernst (BFnpp2013232_CR9) 2009; 65 SF McTavish (BFnpp2013232_CR20) 1999; 13 F da Silva Alves (BFnpp2013232_CR7) 2011; 25 GD Stuber (BFnpp2013232_CR36) 2008; 321 M Leyton (BFnpp2013232_CR17) 2000; 24 SF McTavish (BFnpp2013232_CR21) 1999; 141 EA Moja (BFnpp2013232_CR27) 1996; 58 JM Bjork (BFnpp2013232_CR2) 2004; 24 B Knutson (BFnpp2013232_CR15) 2001; 21 WH Oldendorf (BFnpp2013232_CR29) 1973; 224 D Wilkinson (BFnpp2013232_CR39) 2004; 5 GS Dichter (BFnpp2013232_CR8) 2012; 136 W Schultz (BFnpp2013232_CR32) 2007; 30 SN Haber (BFnpp2013232_CR10) 2010; 35 SF McTavish (BFnpp2013232_CR25) 2001; 424 T Silverstone (BFnpp2013232_CR33) 1983; 13 N Coupland (BFnpp2013232_CR6) 2001; 26 DM McNair (BFnpp2013232_CR19) 1992 G Biggio (BFnpp2013232_CR1) 1976; 26 DJ Stein (BFnpp2013232_CR34) 2008; 13 KE Lythe (BFnpp2013232_CR18) 2005; 19 M Stoy (BFnpp2013232_CR35) 2012; 26 G Hernandez (BFnpp2013232_CR14) 2007; 121 SF McTavish (BFnpp2013232_CR24) 1999; 13 CJ Harmer (BFnpp2013232_CR11) 2001; 154 JD Milner (BFnpp2013232_CR26) 1986; 35 A Nagano-Saito (BFnpp2013232_CR28) 2012; 108 JM Bjork (BFnpp2013232_CR3) 2008; 42 K Blum (BFnpp2013232_CR4) 2000; 32 RM Palmour (BFnpp2013232_CR30) 1998; 136 B Knutson (BFnpp2013232_CR16) 2009 SF McTavish (BFnpp2013232_CR23) 2005; 30 P van Ruitenbeek (BFnpp2013232_CR38) 2009; 157 AE Harper (BFnpp2013232_CR12) 1970; 50 JW Buckholtz (BFnpp2013232_CR5) 2010; 13 G Hasler (BFnpp2013232_CR13) 2009; 66 BH Schott (BFnpp2013232_CR31) 2008; 28 SY Tam (BFnpp2013232_CR37) 1997; 53 SF McTavish (BFnpp2013232_CR22) 2004; 175 |
References_xml | – volume: 24 start-page: 459 year: 2000 ident: BFnpp2013232_CR17 publication-title: Alcohol Clin Exp Res doi: 10.1111/j.1530-0277.2000.tb02012.x – volume: 32 start-page: 1 issue: Suppl i–iv year: 2000 ident: BFnpp2013232_CR4 publication-title: J Psychoactive Drugs doi: 10.1080/02791072.2000.10736099 – volume: 25 start-page: 538 year: 2011 ident: BFnpp2013232_CR7 publication-title: J Psychopharmacol doi: 10.1177/0269881110367731 – volume: 35 start-page: 4 year: 2010 ident: BFnpp2013232_CR10 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2009.129 – volume: 30 start-page: 203 year: 2007 ident: BFnpp2013232_CR32 publication-title: Trends Neurosci doi: 10.1016/j.tins.2007.03.007 – volume: 157 start-page: 92 year: 2009 ident: BFnpp2013232_CR38 publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.2009.00203.x – volume: 58 start-page: 2389 year: 1996 ident: BFnpp2013232_CR27 publication-title: Life Sci doi: 10.1016/0024-3205(96)00242-1 – volume: 136 start-page: 1126 year: 2012 ident: BFnpp2013232_CR8 publication-title: J Affect Disord doi: 10.1016/j.jad.2011.09.048 – volume: 66 start-page: 201 year: 2009 ident: BFnpp2013232_CR13 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2009.02.029 – volume: 13 start-page: 379 year: 1999 ident: BFnpp2013232_CR20 publication-title: J Psychopharmacol doi: 10.1177/026988119901300408 – volume: 30 start-page: 786 year: 2005 ident: BFnpp2013232_CR23 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300665 – volume: 141 start-page: 182 year: 1999 ident: BFnpp2013232_CR21 publication-title: Psychopharmacology (Berl) doi: 10.1007/s002130050823 – volume: 53 start-page: 441 year: 1997 ident: BFnpp2013232_CR37 publication-title: Biochem Pharmacol doi: 10.1016/S0006-2952(96)00774-5 – volume: 35 start-page: 875 year: 1986 ident: BFnpp2013232_CR26 publication-title: Biochem Pharmacol doi: 10.1016/0006-2952(86)90071-7 – volume: 26 start-page: 677 year: 2012 ident: BFnpp2013232_CR35 publication-title: J Psychopharmacol doi: 10.1177/0269881111416686 – volume: 224 start-page: 967 year: 1973 ident: BFnpp2013232_CR29 publication-title: Am J Physiol doi: 10.1152/ajplegacy.1973.224.4.967 – volume: 13 start-page: 561 year: 2008 ident: BFnpp2013232_CR34 publication-title: CNS Spectr doi: 10.1017/S1092852900016837 – volume: 424 start-page: 115 year: 2001 ident: BFnpp2013232_CR25 publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(01)01105-0 – volume: 50 start-page: 428 year: 1970 ident: BFnpp2013232_CR12 publication-title: Physiol Rev doi: 10.1152/physrev.1970.50.3.428 – volume: 13 start-page: 251 year: 1983 ident: BFnpp2013232_CR33 publication-title: Psychol Med doi: 10.1017/S0033291700050856 – volume: 26 start-page: 247 year: 2001 ident: BFnpp2013232_CR6 publication-title: J Psychiatry Neurosci – volume-title: Profile of Mood States year: 1992 ident: BFnpp2013232_CR19 – volume: 19 start-page: 5 year: 2005 ident: BFnpp2013232_CR18 publication-title: J Psychopharmacol doi: 10.1177/0269881105048886 – volume: 136 start-page: 1 year: 1998 ident: BFnpp2013232_CR30 publication-title: Psychopharmacology (Berl) doi: 10.1007/s002130050532 – volume: 21 start-page: RC159 year: 2001 ident: BFnpp2013232_CR15 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.21-16-j0002.2001 – volume: 175 start-page: 124 year: 2004 ident: BFnpp2013232_CR22 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-004-1945-0 – volume: 108 start-page: 501 year: 2012 ident: BFnpp2013232_CR28 publication-title: J Neurophysiol doi: 10.1152/jn.00592.2011 – volume: 5 start-page: 67 year: 2004 ident: BFnpp2013232_CR39 publication-title: Nat Rev Neurosci doi: 10.1038/nrn1302 – volume: 24 start-page: 1793 year: 2004 ident: BFnpp2013232_CR2 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4862-03.2004 – volume: 121 start-page: 887 year: 2007 ident: BFnpp2013232_CR14 publication-title: Behav Neurosci doi: 10.1037/0735-7044.121.5.887 – volume: 28 start-page: 14311 year: 2008 ident: BFnpp2013232_CR31 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2058-08.2008 – volume: 26 start-page: 1253 year: 1976 ident: BFnpp2013232_CR1 publication-title: J Neurochem doi: 10.1111/j.1471-4159.1976.tb07014.x – volume: 321 start-page: 1690 year: 2008 ident: BFnpp2013232_CR36 publication-title: Science doi: 10.1126/science.1160873 – volume: 13 start-page: 144 year: 1999 ident: BFnpp2013232_CR24 publication-title: J Psychopharmacol doi: 10.1177/026988119901300205 – volume: 13 start-page: 419 year: 2010 ident: BFnpp2013232_CR5 publication-title: Nat Neurosci doi: 10.1038/nn.2510 – volume: 65 start-page: 316 year: 2009 ident: BFnpp2013232_CR9 publication-title: Ann Neurol doi: 10.1002/ana.21594 – start-page: 389 volume-title: Neuroeconomics: Decision-Making and the Brain year: 2009 ident: BFnpp2013232_CR16 doi: 10.1016/B978-0-12-374176-9.00025-7 – volume: 154 start-page: 105 year: 2001 ident: BFnpp2013232_CR11 publication-title: Psychopharmacology (Berl) doi: 10.1007/s002130000613 – volume: 42 start-page: 1609 year: 2008 ident: BFnpp2013232_CR3 publication-title: NeuroImage doi: 10.1016/j.neuroimage.2008.06.035 |
SSID | ssj0015768 |
Score | 2.2408442 |
Snippet | Dopamine (DA) neurotransmission is critical for motivational processing. We assessed whether disruption of DA synthesis in healthy controls using an amino-acid... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 595 |
SubjectTerms | Addictive behaviors Adult Alcoholism Amino Acids - blood Amphetamines Analysis of Variance Behavior Biological and medical sciences Brain Mapping Brain research Catecholamines Dopamine Double-Blind Method Drug abuse Female Food, Formulated Humans Image Processing, Computer-Assisted Magnetic Resonance Imaging Male Medical sciences Motivation - drug effects Motivation - physiology Neurosciences Nucleus Accumbens - blood supply Nucleus Accumbens - drug effects Nucleus Accumbens - physiology Original Oxygen - blood Phenylalanine - deficiency Phlebotomy Reaction Time - physiology Reward Tyrosine - deficiency Young Adult |
Title | Dietary Tyrosine/Phenylalanine Depletion Effects on Behavioral and Brain Signatures of Human Motivational Processing |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23995581 https://www.proquest.com/docview/1477437479 https://www.proquest.com/docview/1490757591 https://www.proquest.com/docview/1496888492 https://pubmed.ncbi.nlm.nih.gov/PMC3895237 |
Volume | 39 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF-0BRGK6NWP03qsoH2xsdnsbrL7JD3bUoQrh55wbyHZD3vQ5mIvfch_70ySy3mifQkJmcCSmZ39zc7sbwh5r5Mwx-A48Cb2gYgc-MHY8SBy2obeZS5qijEnl_HFD_F1LufdhtuqK6tc-8TGUdulwT3yYyYAqHAAv_pz-SvArlGYXe1aaDwku0hdhladzPuAiyGWblCk5gHEYvOu8D3k6rgokayS8U8Rj7aWpL0yW8Hf8W1bi3_hzr_LJ_9Yj86fkicdkKQnreafkQeuGJD9kwKC6JuaHtKmtLPZMx-QR5Mugz4gh9OWq7o-orPN0avVUfNFz2Jd75PqdOGq7LamsxpGjWwa0ytX1NdYCglP9NSVyNu9LGhLgLyicDvuD_3TrLB0jP0n6PfFz5Y-FEQ8bbIGdNK3VQPR7rACLKLPyez8bPblIuhaNARGClYFwuQSIyDLpfBh7o0BJ2BMxHweSxtLY-HCPDPIf6yF1E7l2odMZZpbcDYvyE6xLNwrQlUmQp9xnoXcCstsrpxUOQCy2IdcOjUkH9dKSk1HX45dNK7TJo3OVQoqTVGlKah0SD700mVL2_EfudGWvnthjEQ542xIDtYGkHaze5VubHFI3vWvYV5isiUr3PIOZTSgsURqdq9MrJQSGsbxsrWpzQDwzLFU8HWyZW29APKCb78pFlcNPzhgUBnx5PX9Q39DHsNfEG0F-gHZqW7v3FsAWFU-ambRiOyOzy6n334DYiYp2g |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkAAJIej4KIxhJLYXFhbHdmo_ILRRpo6t0ySK1LcocWxWaaRlyYTyR_E_cpevUgR720uUKJfIyp3Pv8udf0fIGz3wEwyOPWdC54nAgh8MLfcCq1Pf2dgGVTHm-DQcfRWfp3K6Rn61e2GwrLL1iZWjTucG_5HvMQFAhQP41R8WPzzsGoXZ1baFRm0Wx7b8CSFb_v5oCPrdDoLDT5OPI6_pKuAZKVjhCZNIBO0pl8L5iTMG7NaYgLkklGkoTQoH5phByl4tpLYq0c5nKtY8hfkBr71FbsO662OsN5h28R1D6F6BVs09CP2mTZ29z9VetkBuTMbfBTxYWQHvL-IclOHqLhr_grl_V2v-sfwdPiQPGtxK92tDe0TWbNYjG_sZxOzfS7pDq0rS6hd9j9wZNwn7Htk5q6mxy106We70ynerJzrS7HKDFMOZLeLLkk5KGDWSd5yd26y8wMpLuKJDu0Ca8HlGa77lnMLpQccxQOMspQfY7oJ-mX2r2UpBxNEqSUHHXRc3EG32RsCa_ZhMbkJ3T8h6Ns_sM0JVLHwXcx77PBUpSxNlpUoA_4XO59KqPnnbKikyDVs6Nu24iKqsPVcRqDRClUag0j7Z7qQXNUvIf-S2VvTdCWPgyxlnfbLZGkDUOJM8Wpp-n7zuboMbwNxOnNn5FcpoAH8Dqdm1MqFSSmgYx9PappYDwC3OUsHTgxVr6wSQhnz1TjY7r-jIAfLKgA-eXz_0V-TuaDI-iU6OTo9fkHvwRURd_L5J1ovLK_sSsF2RbFUzipLohmfwb7eSZCM |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTpqQEIKOj8IYRmJ7YaFxbKf2A0IrXbUxWlVQpL5FiWOzSiMtayeUP43_jnOSphTB3vZStcqlsnIf_l3u_DuA16rjJy459qwOrccDg3EwNMwLjEp9a2ITFM2Yg2F4-pV_nIjJFvxanYVxbZWrmFgE6nSm3TvyNuUIVBiCX9W2VVvEqNd_P__huQlSrtK6GqdRmsi5yX9i-rZ4d9ZDXR8EQf9k_OHUqyYMeFpwuvS4ToQD8CkT3PqJ1RptWOuA2iQUaSh0ih_UUu3oexUXyshEWZ_KWLEUfQX_9g5sd1xS1IDt7slw9LkuYTggX0BYxTxMBCdV173PZDubO6ZMyt4GLNjYD-_N4wWqxpYzNf4Fev_u3fxjM-w_gPsViiXHpdk9hC2TNWH3OMMM_ntODknRV1q8sG_CzqAq3zfhcFQSZedHZLw-97U4Ku6oKbTzXVj2pmYZX-VknOOqHZXH6MJk-aXrw8RfpGfmjjR8lpGSfXlB8Gu3ZhwgcZaSrht-Qb5Mv5XcpShiSVGyIIN6phuKViclcAd_BOPb0N5jaGSzzDwFImPu25ix2GcpT2maSCNkgmgwtD4TRrbgzUpJka64090Ij8uoqOEzGaFKI6fSCFXagoNael5yhvxHbn9D37WwS4MZZbQFeysDiKrQsojWjtCCV_VlDAqu0hNnZnbtZBRCwY5Q9EaZUErJFa7jSWlT6wW4A89C4t2dDWurBRwp-eaVbHpRkJMjABYB6zy7eekvYQe9N_p0Njx_DnfxgfCyE34PGsura_MCgd4y2a9cikB0y078GzcIab4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dietary+tyrosine%2Fphenylalanine+depletion+effects+on+behavioral+and+brain+signatures+of+human+motivational+processing&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Bjork%2C+James+M&rft.au=Grant%2C+Steven+J&rft.au=Chen%2C+Gang&rft.au=Hommer%2C+Daniel+W&rft.date=2014-02-01&rft.eissn=1740-634X&rft.volume=39&rft.issue=3&rft.spage=595&rft_id=info:doi/10.1038%2Fnpp.2013.232&rft_id=info%3Apmid%2F23995581&rft.externalDocID=23995581 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon |